FI961098A - Menetelmä progestogeniä ja estrogeniä sisältävän korvikkeen valmistamiseksi - Google Patents

Menetelmä progestogeniä ja estrogeniä sisältävän korvikkeen valmistamiseksi Download PDF

Info

Publication number
FI961098A
FI961098A FI961098A FI961098A FI961098A FI 961098 A FI961098 A FI 961098A FI 961098 A FI961098 A FI 961098A FI 961098 A FI961098 A FI 961098A FI 961098 A FI961098 A FI 961098A
Authority
FI
Finland
Prior art keywords
estrogen
pct
progestogen
making
periodicity
Prior art date
Application number
FI961098A
Other languages
English (en)
Swedish (sv)
Other versions
FI961098A0 (fi
Inventor
Philippe Robert Marie Koninckx
Original Assignee
Saturnus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saturnus Ag filed Critical Saturnus Ag
Publication of FI961098A0 publication Critical patent/FI961098A0/fi
Publication of FI961098A publication Critical patent/FI961098A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
FI961098A 1993-09-09 1996-03-08 Menetelmä progestogeniä ja estrogeniä sisältävän korvikkeen valmistamiseksi FI961098A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9301562A NL9301562A (nl) 1993-09-09 1993-09-09 Preparaat voor substitutietherapie.
PCT/EP1994/002997 WO1995007081A1 (en) 1993-09-09 1994-09-08 Preparation for substitution therapy, containing at least one progestogen and at least one extrogen

Publications (2)

Publication Number Publication Date
FI961098A0 FI961098A0 (fi) 1996-03-08
FI961098A true FI961098A (fi) 1996-04-03

Family

ID=19862861

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961098A FI961098A (fi) 1993-09-09 1996-03-08 Menetelmä progestogeniä ja estrogeniä sisältävän korvikkeen valmistamiseksi

Country Status (12)

Country Link
US (1) US5827843A (fi)
EP (1) EP0717626B1 (fi)
JP (1) JPH09502194A (fi)
KR (1) KR960704553A (fi)
CN (1) CN1076969C (fi)
AT (1) ATE241362T1 (fi)
AU (1) AU708881B2 (fi)
DE (1) DE69432752T2 (fi)
FI (1) FI961098A (fi)
HU (1) HU224818B1 (fi)
NL (1) NL9301562A (fi)
WO (1) WO1995007081A1 (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
US6506390B2 (en) 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
AU3888597A (en) * 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
CN1119999C (zh) * 1996-07-26 2003-09-03 惠氏公司 口服避孕药
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
HRP20020666B1 (en) * 2000-01-18 2011-07-31 Bayer Schering Pharma Aktiengesellschaft Drospirenone for hormone replacement therapy
BR0107683A (pt) * 2000-01-18 2002-11-12 Schering Ag Drospirenona para terapia de reposição de hormÈnio
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
EP1857110A3 (en) * 2001-03-16 2008-08-06 Wyeth Hormone replacement therapy
EA200301022A1 (ru) * 2001-03-16 2004-02-26 Уайт Гормональная заместительная терапия
WO2002092102A2 (en) * 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
EP1260225A1 (en) * 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
WO2002094276A1 (en) * 2001-05-18 2002-11-28 Pantarhei Bioscience B.V. Pharmaceutical composition for use in hormone replacement therapy
ATE449606T1 (de) * 2001-05-23 2009-12-15 Pantarhei Bioscience Bv Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption
DE60223795T2 (de) * 2001-05-23 2008-11-27 Pantarhei Bioscience B.V. Tetrahydroxyliertes Östrogen enthaltendes Arzneistoffverabreichungssystem zur Verwendung in der hormonalen Kontrazeption
EP1406634A1 (en) * 2001-07-13 2004-04-14 Schering Aktiengesellschaft Combination of drospirenone and an estrogen sulphamate for hrt
WO2003018026A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
PT1446128E (pt) * 2001-11-15 2007-03-30 Pantarhei Bioscience Bv Utilização de compostos estrogénicos combinados com compostos progestagénicos na terapia hormonal de substituição
WO2003049744A1 (en) 2001-12-05 2003-06-19 Barr Laboratories, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
TW200306846A (en) * 2002-04-03 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
TW200306851A (en) * 2002-04-29 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
WO2003103685A1 (en) * 2002-06-11 2003-12-18 Pantarhei Bioscience B.V. A method of treating human skin and a skin care composition for use in such a method
EP1511496B1 (en) * 2002-06-11 2006-09-27 Pantarhei Bioscience B.V. Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
SI1526856T1 (sl) * 2002-07-12 2008-04-30 Pantarhei Bioscience Bv Farmacevtski sestavek, ki obsega estetrolne derivate za uporabo pri zdravljenju raka
WO2004037269A1 (en) * 2002-10-23 2004-05-06 Pantarhei Bioscience B.V. Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
CN101001631B (zh) * 2003-07-16 2014-08-06 特卫华妇女健康有限公司 利用连续给予雌激素的避孕方案的激素治疗方法
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US8236785B2 (en) * 2007-01-08 2012-08-07 Pantarhei Bioscience B.V. Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
ITMI20122027A1 (it) * 2012-11-28 2014-05-29 Altergon Sa Soluzioni acquose orali di ormoni steroidei e hp¿cd con biodisponibilità ottimizzata

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1021196C (zh) * 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
ES2169030T3 (es) * 1987-09-24 2002-07-01 Jencap Res Ltd Envases de anticonceptivos que contienen estrogeno y progestina.
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product

Also Published As

Publication number Publication date
NL9301562A (nl) 1995-04-03
FI961098A0 (fi) 1996-03-08
HU9600592D0 (en) 1996-05-28
CN1133011A (zh) 1996-10-09
EP0717626B1 (en) 2003-05-28
DE69432752D1 (de) 2003-07-03
WO1995007081A1 (en) 1995-03-16
CN1076969C (zh) 2002-01-02
AU708881B2 (en) 1999-08-12
HUT74452A (en) 1996-12-30
KR960704553A (ko) 1996-10-09
EP0717626A1 (en) 1996-06-26
AU7695294A (en) 1995-03-27
US5827843A (en) 1998-10-27
JPH09502194A (ja) 1997-03-04
DE69432752T2 (de) 2004-04-08
ATE241362T1 (de) 2003-06-15
HU224818B1 (en) 2006-02-28

Similar Documents

Publication Publication Date Title
FI961098A0 (fi) Menetelmä progestogeniä ja estrogeniä sisältävän korvikkeen valmistamiseksi
MX9802130A (es) Agonistas adrenergicos beta3 selectivos.
ATE195740T1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
UA32636C2 (uk) Засіб для зниження вмісту холестерину в сироватці крові людини
IL111077A0 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
NO994275L (no) Nikotinsyrepreparater til behandling av hyperlipidemi og tilknyttede fremgangsmaater
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
AU7496894A (en) Antiglucocorticoid steroids for the treatment of anxiety disorders
AU7077096A (en) Selective beta 3 adrenergic agonists
IL112059A0 (en) A transdermal therapeutic composition containing a deuterated active substance
CA2173403A1 (en) External Therapeutic Composition for Dermatitis
GB1474424A (en) Pharmaceutical composition for treating diabetic ketoacidosis
NO955084L (no) Estrensteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder
NO911508L (no) Nytt s-timololderivat og fremgangsmaate for dets fremstilling.
CA2171460A1 (en) Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору
MXPA94000108A (es) Terapia transdermal de reemplazo de hormonas.
IL108283A0 (en) Use of riluzole for promoting restoration following radiation
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie
UA30912A (uk) Спосіб терапії хворих на хронічний обструктивний бронхіт
UA28966A (uk) Спосіб лікування ішемічної хвороби серця

Legal Events

Date Code Title Description
FD Application lapsed